Autoimmune disease care in Denver

While living with an autoimmune disorder may be difficult, it can be managed.

With autoimmune disorders, your immune system is typically weaker, putting you at a higher risk of developing blood cancers. At Colorado Blood Cancer Institute, we understand this connection, and apply our advanced expertise to the treatment of autoimmune disorders.

Make an appointment

If you're living with an autoimmune disease, let our team help create a care plan for you.

For additional information on autoimmune disorder treatment at our facility, call (720) 754-4800.

Autoimmune disease treatments we offer

Autoimmune diseases can be difficult to manage and treat, but we offer a variety of therapies and clinical trials to advance our medical practices and improve lives.

Multiple sclerosis (MS) care

MS is a chronic disease where the immune system attacks the areas around the nerves in the brain and spinal cord. Common symptoms include fatigue, numbness, vision problems and dizziness.

Our team have decades of experience using autologous hematopoietic stem cell transplantation (AHSCT) to treat MS. This procedure helps rest the immune system, adding new blood-forming stem cells from the same person. With this treatment, our goal is to prevent further clinical relapses, brain lesions and worsening disability, particularly in the earliest stages of the disease.

AHSCT is available to those with substantial MS disease activity, despite treatment with MS medications, known as disease modifying therapies (DMTs). It is also available to those with relapsing MS who meet specific characteristics. Age, time since diagnosis, recent disease activity and your level of disability will all be considered when screening for eligibility. You must have failed one or more disease modifying therapies to be eligible for AHSCT.

Clinical trials for MS include:

  • BEAT-MS study comparing best available therapy (BAT) and AHSCT
  • CAR T-cell therapy for relapsing-remitting multiple sclerosis (RRMS), secondary-progressive multiple sclerosis (SPMS) and primary-progressive multiple sclerosis (PPMS)

Neurological autoimmune disease clinical trials

A neurological autoimmune disease occurs when an immune system is weak and attacks the components of a nervous system. This invokes an abnormal immune response. With advanced treatments, such as stem cell transplants, we can help you prevent attacks on healthy tissues in the body.

We are currently developing clinical trials for the following autoimmune conditions:

  • Autoimmune cerebellar degeneration
  • Autoimmune peripheral neuropathy
  • Chronic inflammatory demyelinating polyneuropathy (CIDP)
  • Gait ataxia with late age onset polyneuropathy (GALOP)
  • Human T-cell lymphotropic virus (HTLV)-1-associated myelopathy (HAM)/Tropical spastic paraparesis (TSP)
  • Lambert-Eaton myasthenic syndrome
  • Myasthenia gravis (MG)
  • Neuromyelitis optica
  • Opsoclonus and myoclonus (anti-Ri)
  • Primary central nervous system (CNS) vasculitis
  • Rasmussen’s encephalitis
  • Stiff person syndrome and stiff person spectrum disorder (SPS/SPSD)